BACKGROUND: Adipose tissue dysfunction is associated with inflammation, type 2 diabetes mellitus and vascular diseases. Visceral adipose tissue (VAT)-derived adipokines, which are released in the portal circulation may influence liver metabolism. OBJECTIVES: (1) To estimate the contribution of VAT and subcutaneous adipose tissue (SAT) on adipokine levels by measuring differences in adipokine concentrations between the portal draining inferior mesenteric vein and the subclavian vein.
INTRODUCTION
After identifying adipose tissue as an endocrine organ it has become clear that adipose tissue not only functions as a storage depot for triglycerides, but that it is also involved in numerous physiological processes such as regulation of the energy balance, glucose homeostasis, blood pressure and inflammation by the production of adipose tissue-derived adipokines. 1 In obesity, an altered endocrine function of adipose tissue characterized by an increased release of free fatty acids and pro-inflammatory proteins in addition to a decreased secretion of adiponectin, may subsequently lead to dyslipidaemia, hypertension, insulin resistance, type 2 diabetes mellitus and eventually cardiovascular complications. 2 In particular, abdominal obesity with excessive visceral adipose tissue (VAT) has been related to insulin resistance and vascular disease. Owing to the close anatomical position of VAT to the liver, VAT may directly influence liver metabolism by secretion of free fatty acids and adipokines into the portal vein leading to the hepatic production of inflammatory cytokines and coagulation factors. 3 Furthermore, VAT is not only characterized by its anatomical relation to the liver, but VAT also differs in cellular composition and molecular properties from subcutaneous adipose tissue (SAT), which may explain the enhanced secretion of pro-inflammatory proteins in VAT compared with SAT. 4, 5 Further stimulation of the pro-inflammatory environment can be induced by macrophage infiltration in adipose tissue, which is increased in obesity. 6 Not only the amount and body distribution of adipose tissue are associated with metabolic disturbances, but also microscopic morphologic adipose tissue parameters have been related to metabolic disturbances. Adipocyte hypertrophy induces insulin resistance, dyslipidaemia and local inflammation. 7 --10 In addition, obese subjects have a lower capacity to expand the capillary network of adipose tissue and it has been shown that lower adipose tissue capillary densities were related to insulin resistance. 11 Numerous studies have focused on the role of VAT accumulation and fat distribution in the development of metabolic disturbances and vascular diseases, which led to the notion that expansion of SAT is a weaker risk factor than expansion of VAT. 12, 13 However, data on the contribution of the SAT and VAT composition (adipocyte size, extent of macrophage infiltration and adipose tissue capillary density) and the amount of VAT and SAT on circulating adipokine concentrations are relatively scarce.
The objectives of this study are (1) to estimate the contribution of VAT and SAT on adipokine levels by measuring differences in adipokine concentrations between the subclavian vein/systemic venous circulation and the portal draining inferior mesenteric vein, in which adipokines are secreted by VAT, (2) to determine the relation between the quantity and composition of VAT on mesenteric adipokine concentrations and (3) to determine the relation between SAT and VAT quantity and composition on systemic adipokine concentrations in patients undergoing abdominal aortic surgery.
SUBJECTS AND METHODS Subjects
Patients undergoing elective abdominal aortic surgery for aneurysmatic or stenotic aortic disease at the University Medical Center Utrecht or at the Gelderse Vallei Hospital in Ede, The Netherlands were eligible for participation in the study in the period October 2007 to February 2010. Exclusion criteria were hypothyroidism (thyroid-stimulating hormone 45.0 mU l À1 ), premenopausal status, elevated liver enzymes (aspartate aminotransferase or alanine aminotransferase 42 times the upper limit of normal), known malignancy in the past 2 years, usage of thiazolidinediones or a history of liposuction. All female study subjects were postmenopausal and there was no subject on hormone replacement therapy. All study patients gave written informed consent and the procedure for obtaining the blood and tissue samples was approved by the Medical Ethics Committee of the University Medical Center Utrecht.
Adipose tissue biopsies and blood sampling from the inferior mesenteric vein and from the systemic circulation during surgery Venous blood samples were drawn before surgery in fasting state from a peripheral arm vein. During surgery, blood samples were simultaneously obtained from a central venous catheter in the subclavian vein and from the inferior mesenteric vein, which ultimately drains into the portal venous system. Tubes were immediately placed on ice and centrifuged at 1850 g for 15 min at 4 1C. The serum and plasma samples were aliquotted and immediately stored at À80 1C until analyses.
During surgery, approximately 10 g of mesenteric and 10 g of abdominal SAT in the periumbilical region of the laparotomy incision were obtained. One part of these adipose tissue samples was fixed in formalin and embedded in paraffin afterward.
Determination of adipokine and cytokine concentrations in blood samples
The protein concentrations in serum of interleukin (IL)-1 receptor antagonist, IL-1b, IL-6, tumour necrosis factor-a, interferon-g, macrophage chemoattractant protein-1, macrophage inhibitory protein-1a, IL-8, interferon-g-inducible protein-10 (IP-10), macrophage colony-stimulating factor, resistin, nerve growth factor (NGF), hepatic growth factor (HGF), macrophage inhibitory factor, thrombopoietin, adipsin, chemerin, plasminogen activator inhibitor-1, serum amyloid A1, retinol-binding protein-4, leptin, tissue inhibitor of metalloproteinase-1, cathepsinS and adiponectin were measured with a microbead-based Luminex assay (Bio-Rad, Munich, Germany). Fluorophore-labelled microbeads were coated with specific monoclonal antibodies against the aforementioned proteins. The beads coated with capture antibodies were used together with secondary biotinylated antibodies. Measurements and data analysis of all assays were performed on the Bioplex system in combination with Bioplex manager software (Bio-Rad). The analysis protocol as well as the characteristics of the assay have been published previously. 14 Determination of adipocyte size, macrophage infiltration and capillary density in adipose tissue samples
The paraffin-embedded adipose tissue sections were stained with haematoxylin and eosin. Digital images of the haematoxylin and eosin slides were acquired with Leica Qprodit imaging software (Leica Microsystems, Rijswijk, The Netherlands), after which adipocyte size was measured in 100 adipocytes in randomly selected areas of the haematoxylin and eosin slide at Â 200 magnification (Figure 1a) .
In addition, subcutaneous and mesenteric adipose tissue samples were processed for immunohistochemical staining of CD68 and von Willebrand factor (Figure 1b) . To quantify the number of macrophages infiltrating adipose tissue, in each slide CD68-positive cells were counted in 10 different high-power fields of both adipose tissue depots; the mean number of CD68-positive cells per slide was used for data analysis. 
Quantification of subcutaneous and visceral fat depots
Computed tomography (CT) images of the abdomen, which were produced as a standard pre-operative procedure, were obtained in 28 of the 32 patients. Using a single CT-slice at the level of L3/L4 of the lumbar spine, SAT area and VAT area were measured, according to the method described by Irlbeck et al. 15 The muscular abdominal wall was manually traced in order to separate VAT from SAT as the regions of interest. By adjusting the display settings to a window width of À195 to À45 Hounsfield units, the area of adipose tissue could selectively be measured (ImageJ v1.42q, developed by the NIH).
Data analyses
Differences in adipokine and cytokine concentrations between mesenteric and peripheral venous blood samples are presented as the mean difference and 95% confidence interval (95% CI) of the difference.
Linear regression analyses were applied to quantify the relation between adipose tissue measurements (adipose tissue area, adipocyte size, macrophage infiltration and capillary density) and adipokine concentrations. SAT measurements were included in the regression model to describe the relation with adipokine concentrations measured in the subclavian vein, whereas mesenteric adipose tissue measurements were used in the linear regression models as determinants of adipokine concentrations measured in the inferior mesenteric vein. Age and gender were included in all regression models to adjust for potential confounding.
Adipokines concentrations that were not normally distributed were logarithmically transformed. Results of the linear regression analyses are expressed as beta (b) regression coefficients and 95% CI of the regression coefficient.
RESULTS

Baseline characteristics
The majority of the study population undergoing abdominal aortic surgery was male (n ¼ 21, 66%) and the mean age of all patients was 66. 3±8.7 years (Table 1 ). In 72% (n ¼ 23) of the patients, aneurysms of the abdominal aorta determined the indication for abdominal aortic surgery and 28% (n ¼ 9) of the patients underwent surgery because of stenosis or occlusion of the abdominal aorta. Three patients were obese (body mass index (BMI) 430 kg m --2 ) and eight patients were overweight (BMI Macrophages resided predominantly in the interstitial space between the adipocytes; there was no important amount of macrophages organized in 'crown-like structures' around adipocytes.
The correlations between the microscopic adipose tissue measurements and measurements of adiposity are shown in Table 2 . There were significant positive correlations between the variables BMI, waist circumference, CT-based VAT measurements, SAT adipocyte size and VAT adipocyte size. CT-based SAT measurements were significantly correlated with BMI, waist circumference, VAT quantity and SAT macrophages. The SAT capillary density was significantly negatively correlated with SAT adipocyte size as well as VAT adipocyte size. Indication surgery: stenosis of the Abdominal aorta, n (%)
(28)
Medical history
Coronary heart disease, n (%) 15 (47) Cerebrovascular disease, n (%) 3 (9) Peripheral artery disease, n (%) 13 (41) Renal failure (glomerular filtration rate o60 ml min --1 ), n (%) Adipokine concentrations in the mesenteric venous and subclavian venous circulation Considering that VAT secretes its adipokines in the mesenteric venous circulation, the mean difference in adipokine concentrations between the inferior mesenteric vein and the subclavian vein was calculated to investigate the contribution of the VAT depot to adipokine secretion.
Concentrations of adipokines in serum samples from the inferior mesenteric vein and subclavian vein obtained during abdominal surgery are shown in Table 3 . Serum concentrations of IP-10 were 14 pg ml --1 (95% CI 5 --23) higher in the inferior mesenteric vein than in the subclavian vein. HGF concentrations were 48 pg ml --1 (95% CI 1 --93) higher in the inferior mesenteric vein. There were no statistical significant differences between mesenteric and subclavian concentrations with respect to the other adipokines. Serum concentrations of the growth factor macrophage colony-stimulating factor and cytokines IL-1b, IL-6, tumour necrosis factor-a, interferon-g, macrophage inhibitory protein-1a were below the detection limit of the Luminex assay in the majority (X20) of patients. Also, stratification by VAT area was performed to compare mesenteric and systemic adipokine concentration differences between subjects with a low VAT area (below the median VAT area of 143 cm 2 ) and high VAT area (above the median VAT area of 143 cm 2 ; data not shown). In subjects with a low VAT area, IP-10 concentrations were 29 pg ml --1 (15 --42) higher and NGF concentrations were 0.8 pg ml --1 (0.1 --1.6) lower in the inferior mesenteric vein. In contrast, in subjects with a high VAT area resistin and macrophage chemoattractant protein-1 concentrations were significantly higher in the inferior mesenteric vein, respectively 1027 pg ml --1 (322 --1731) and 9.3 pg ml --1 (3.9 --14.6). In conclusion, except for IP-10 and HGF there were no significant differences in adipokine concentrations between the inferior mesenteric vein and the subclavian vein. Whereas subjects with a relatively low VAT area demonstrated significantly different NGF and IP-10 concentrations in the inferior mesenteric vein vs the subclavian vein, subjects with a larger amount of VAT had higher levels of resistin and macrophage chemoattractant protein-1 in the inferior mesenteric vein.
The relation between the quantity and composition of VAT and mesenteric adipokine concentrations To quantify the relation between both VAT quantity and composition and adipokine concentrations in the inferior mesenteric vein linear regression analyses with adjustments for gender and age were applied (Table 4 ). An increase in CT-measured VAT area was significantly related to levels of mesenteric adiponectin. With every 1 cm 2 increase in VAT area, the mesenteric adiponectin concentration decreased with 20 ng ml --1 (b À20; 95% CI À35 to À5). On microscopic level, larger adipocytes (per 1000 mm 2 increase in visceral adipocyte size) were related to lower concentrations of adiponectin (b À1076; 95% CI À1624 to À527). Moreover, increases in VAT capillary density led to lower (log)NGF levels (b À0.299; 95% CI À0.505 to À0.093). VAT macrophage infiltration was not significantly related to any adipokine concentration. Additional adjustment for the potential confounding factors smoking and statin use did not result in substantial changes of the b-regression coefficients (data not shown).
The relation between the quantity and composition of SAT and VAT and systemic adipokine concentrations In addition to the relation between VAT measurements and mesenteric adipokine concentration, regression analyses were performed to assess (1) the relation between SAT measurements and systemic adipokine concentrations and (2) to assess the relation between VAT measurements and systemic adipokine concentrations.
A larger SAT quantity on CT imaging was significantly related to the subclavian venous/systemic concentrations of (log)leptin (b 0.003; 95% CI 0.001 to 0.004) and adiponectin (b À18; 95% CI À35 to À2) (Table 5a) . Also, the size of SAT adipocytes was significantly associated with lower systemic adiponectin concentrations (b À488; 95% CI À938 to À38), higher serum concentrations of retinol-binding protein-4 (b 4.9; 95% CI 1.1 to 8.6) and tissue inhibitor of metalloproteinase-1 (b 6.4; 95% CI 2.1 to 10.8). Macrophage infiltration in SAT was related to lower systemic adiponectin levels (b À1439; 95% CI À2387 to 491). The density of the capillary network in SAT was not related to systemic concentrations of any of the measured adipokines.
In addition to the relation between SAT quantity and composition with systemic adipokine concentrations, increases in VAT area and visceral adipocyte size were significantly associated with lower systemic adiponectin concentrations (respective b-values: b À12; 95% CI À22 to À1 and b À637; 95% CI À1063 to À212). Conversely, increases in VAT capillary density were related to higher adiponectin concentrations in the subclavian vein (b 1486; 95% CI 49 to 2923) (Table 5b ). Furthermore, visceral adipocyte size was a significant determinant of systemic tissue inhibitor of metalloproteinase-1 (b 4.9; 95% CI 0.2 to 9.6) and VAT capillary density was significantly associated with systemic (log)NGF concentrations (b À0.291; 95% CI À0.510 to À0.072). All regression coefficients were adjusted for age and gender; additional adjustments for smoking and statin use did not lead to substantial changes in beta regression coefficients.
DISCUSSION
In patients undergoing abdominal aortic surgery, no significant differences in adipokine concentrations were measured between the inferior mesenteric vein and subclavian vein, except for significant higher levels of IP-10 and HGF in the inferior mesenteric vein. Increases in SAT and VAT quantity as well as adipocyte size and SAT macrophage infiltration are significantly related to lower adiponectin plasma concentrations, while VAT capillary density is associated with increased systemic adiponectin concentrations.
Previously, in a study with 25 morbidly obese patients (BMI 54.7±12.6 kg m --2 ), undergoing gastric bypass surgery, the concentrations of the pro-inflammatory cytokine IL-6 were approximately 50% higher in the portal vein than in the radial artery. 5 Furthermore, these patients had approximately 20% lower leptin concentrations in the portal vein. In contrast with these data, we demonstrate equal levels of pro-inflammatory cytokines and leptin in the systemic circulation and in the inferior mesenteric vein, in a broad panel of pro-inflammatory cytokines and À18 (À35 to À2)* À488 (À938 to À38)* À1439 (À2387 to À491)** 1415 (À419 to 3249)
Abbreviations: CI, confidence interval; HGF, hepatic growth factor; IL, interleukin; IP-10, interferon-g-inducible protein 10; MCP, macrophage chemoattractant protein; MIF, macrophage inhibitory factor; NGF, nerve growth factor; PAI-1, plasminogen activator inhibitor-1; RA, receptor antagonist; RBP4, retinol-binding protein-4; SAA1, serum amyloid A1; SAT, subcutaneous adipose tissue; TIMP, tissue inhibitor of metalloproteinase. *P-value o0.05. **P-value o0.01. adipokines. In this study, most pro-inflammatory cytokines remained well below the detection limit of the assay, indicating low levels of systemic inflammation. Excess of VAT may be responsible for a relatively large proportion of systemically circulating IL-6 in morbidly obese subjects, 16, 17 which may explain the higher portal levels of IL-6. The absence of obesity in the majority of the patients in this study may account for the absence of a difference between mesenteric and subclavian IL-6 concentrations.
Similarly, there were no significant differences in leptin concentrations between both venous sampling sites in this study. Considering that leptin secretion is 2-to 3-times higher in SAT than in omental adipose tissue, 18 it is more likely to observe higher leptin concentrations in systemic venous blood samples than in mesenteric venous blood in which VAT-derived adipokines are excreted. Higher leptin concentrations occurring in leptinresistant obese subjects, 19 may enhance the contrast between the systemic --mesenteric leptin gradient and may thus explain the absence of a leptin concentration difference in this study with generally non-obese patients. The significant relation between SAT area and leptin suggests that SAT is the primary determinant for plasma leptin concentrations, which is consistent with previous in vitro and in vivo data. 18, 20, 21 Most prominently, being specifically synthesized in adipocytes, adiponectin levels are influenced by the several SAT and VAT measurements, which were performed in this study. Various beneficial characteristics have been attributed to adiponectin, such as insulin sensitizing, anti-atherosclerotic and anti-inflammatory properties. 22 Differing from other adipokines, adiponectin levels typically decrease in obese states 23 and with increasing subcutaneous adipocyte size. 24 The current data show that increased SAT and VAT mass and increased subcutaneous and visceral adipocyte size result in lower adiponectin concentrations. Local adipose tissue inflammation in adiposity, characterized by an increased local production of pro-inflammatory cytokines 25 and increased adipose tissue macrophage infiltration, has been suggested to interfere with adiponectin secretion. Adiponectin levels significantly decreased with increasing numbers of SAT macrophages in this study. It has been hypothesized that intracellular hypoxia because of adipocyte hypertrophia and insufficient adipose tissue vascularisation may precede local adipose tissue inflammation and further changes in adipokine secretion. 26 Data from this study show that an increased VAT capillary density was associated with increased systemic adiponectin levels.
Although no differences in cytokine and adipokine concentrations were found between both venous sampling sites, small but significant increases in concentrations of the chemokine IP-10 and growth factor/angiogenic factor HGF were measured in the inferior mesenteric vein.
IP-10 has chemoattractant properties for several immune cells such as monocytes, activated T-lymphocytes and dendritic cells, which have been implicated to initiate macrophage infiltration in adipose tissue in obese states. 27 Various cell types, including macrophages, endothelial cells and fibroblasts, secrete IP-10 but also human adipocytes. 28, 29 The results of our study, showing significantly higher IP-10 concentrations in the inferior mesenteric vein vs the subclavian vein, support the findings that VAT is an active site of IP-10 secretion.
HGF, which has been associated with atherogenesis 30,31 and type 2 diabetes mellitus, 32 correlated linearly with BMI in previous studies. 32, 33 Furthermore, high levels of HGF expression were found in white adipose tissue. 4, 34 There are no data, however, concerning the contribution of a specific adipose tissue depot in the production of HGF. The current results indicate that specifically VAT, may have a contribution to HGF concentrations.
The strengths of this study include the simultaneous measurement of a broad panel of adipokines at two different venous sampling sites under standardized conditions in a relevant group of patients. Also, different methods were used to measure adiposity, ranging from BMI and waist circumference to CT-based measurements of adipose tissue, which could be compared with histological analyses of adipose tissue biopsies. Finally, to our knowledge this is the first study to describe the contribution of VAT and SAT to adipokine concentrations in generally lean patients.
Some limitations of the study have to be considered. The study population consisted solely of patients with aortic vascular disease. Differences in the severity of aortic vascular disease may have contributed to differences in adipokine and cytokine concentrations. Also, it is conceivable that there are differences between groups of patients with aneurysmatic vascular disease and occlusive vascular disease. These groups are too small to perform stratified analyses. In addition, because of the relatively limited sample size of this study some associations may not have reached the level of significance; gender differences in VAT and SAT area were not significant in this study, although sex differences in body fatness and adipose tissue distribution have been well documented in previous studies. 16, 35, 36 All samples were obtained during a surgical procedure; general anaesthesia, mechanical ventilation and administered drugs may have influenced adipokine concentrations. Furthermore, it has been described that superficial and deep SAT may be metabolically distinct. 37 --40 However, with the CT-based SAT measurements performed in this study no discrimination could be made between superficial and deep SAT, which may have influenced the results. Also, no distinction could be made between the two SAT subcompartments during analysis of the histological slides.
In conclusion, increased SAT and VAT masses as well as morphologic characteristics of both adipose tissue depots are related to systemic and mesenteric adipokine concentrations; particularly adiponectin levels are consistently influenced by the amount and composition of SAT and VAT. In contrast, leptin concentrations were specifically affected by the quantity of SAT. Except for higher IP-10 and HGF concentrations in the inferior mesenteric vein, there were no other differences in adipokine concentrations in the mesenteric vein and the systemic circulation, indicating a possible contribution of VAT to IP-10 and HGF levels.
